StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
70
This month
2
This year
5
Publishing Date
2023 - 12 - 27
2
2023 - 11 - 30
1
2023 - 11 - 22
1
2023 - 11 - 08
1
2023 - 09 - 06
1
2023 - 08 - 08
1
2023 - 07 - 14
1
2023 - 06 - 27
1
2023 - 06 - 06
1
2023 - 06 - 05
1
2023 - 05 - 31
1
2023 - 05 - 05
1
2023 - 04 - 20
1
2023 - 04 - 17
1
2023 - 04 - 04
1
2023 - 03 - 21
1
2023 - 03 - 02
1
2023 - 03 - 01
1
2023 - 01 - 17
1
2023 - 01 - 11
1
2023 - 01 - 09
2
2022 - 12 - 05
1
2022 - 11 - 16
1
2022 - 10 - 24
1
2022 - 10 - 14
1
2022 - 09 - 19
1
2022 - 08 - 23
1
2022 - 08 - 03
1
2022 - 07 - 28
1
2022 - 07 - 20
1
2022 - 07 - 18
1
2022 - 07 - 14
1
2022 - 07 - 04
1
2022 - 06 - 22
1
2022 - 06 - 21
1
2022 - 06 - 15
1
2022 - 06 - 13
1
2022 - 04 - 26
1
2022 - 02 - 23
1
2022 - 02 - 04
1
2022 - 01 - 28
1
2022 - 01 - 24
1
2022 - 01 - 19
1
2022 - 01 - 14
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 08
1
2021 - 12 - 02
1
2021 - 11 - 30
1
2021 - 11 - 24
1
2021 - 11 - 19
1
2021 - 11 - 17
1
2021 - 11 - 01
1
2021 - 10 - 21
1
2021 - 10 - 13
1
2021 - 10 - 08
1
2021 - 09 - 22
2
2021 - 09 - 20
1
2021 - 09 - 09
2
2021 - 09 - 07
1
Sector
Energy minerals
1
Health technology
70
Tags
Acquisition
2
Agreement
2
Als
8
Application
3
Approval
1
Australia
1
Biocanada
6
Cancer
2
Capacity
1
Care
1
Ceo
3
Chinese
2
Chronic cough
5
Clinical-trials-phase-ii
6
Conference
4
Depression
1
Designation
2
Disease
2
Drug
8
Enroll
2
Events
1
Fda
6
Fibrosis
6
Financial
1
Global
1
Grant
3
Group
1
Growth
1
Intel
1
Ipo
1
Japan
1
Kidney
2
Liver
1
Lung cancer
2
Management
1
Money
2
N/a
39
Nash
4
Neurological
1
Offering
5
Ongoing
1
Patent
10
People
3
Pharmaceutical
6
Pharmaceuticals
28
Phase 1
6
Phase 2
19
Phase 2b
4
Phase 3
2
Positive
4
Potential
1
Pre-clinical
2
Preclinical
2
Program
5
Research
11
Stroke
10
Study
11
Treat
2
Treatment
7
Trial
3
Entities
Algernon pharmaceuticals inc.
70
Genoil inc
1
Medicure inc
1
Sanofi
1
Symbols
AAPL
1193
ABB
1423
ABBV
1023
ABLZF
1162
ABT
1784
ACN
600
AMGN
742
ARVL
4285
AZN
664
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
895
DHR
785
ERIC
1607
F
641
FNCTF
7171
FRBA
595
GE
915
GLAXF
657
GOOG
1274
GOOGL
1273
GSK
883
HON
1779
HUBS
1400
IBM
654
INTC
954
IT
590
JNJ
4571
LLY
1708
LTUM
970
LYV
717
MDT
1285
MMM
938
MS
4279
MSFT
1199
MT
588
NOC
588
NOK
898
NOKBF
972
NVO
631
NVS
1241
NVSEF
1031
ORCL
1157
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1126
PPRUY
1127
SAP
1474
SAPGF
1228
SNOW
794
SNY
4532
SNYNF
3590
TEVJF
630
TMO
1621
VZ
1211
XYF
674
Exchanges
Nasdaq
70
Crawled Date
2023 - 12 - 27
2
2023 - 11 - 30
1
2023 - 11 - 22
1
2023 - 11 - 08
1
2023 - 09 - 06
1
2023 - 08 - 08
1
2023 - 07 - 14
1
2023 - 06 - 27
1
2023 - 06 - 06
1
2023 - 06 - 05
1
2023 - 05 - 31
1
2023 - 05 - 05
1
2023 - 04 - 20
1
2023 - 04 - 17
1
2023 - 04 - 04
1
2023 - 03 - 21
1
2023 - 03 - 02
1
2023 - 03 - 01
1
2023 - 01 - 17
1
2023 - 01 - 11
1
2023 - 01 - 09
2
2022 - 12 - 05
1
2022 - 11 - 16
1
2022 - 10 - 24
1
2022 - 10 - 14
1
2022 - 09 - 19
1
2022 - 08 - 23
1
2022 - 08 - 03
1
2022 - 07 - 28
1
2022 - 07 - 20
1
2022 - 07 - 18
1
2022 - 07 - 14
1
2022 - 07 - 04
1
2022 - 06 - 22
1
2022 - 06 - 21
1
2022 - 06 - 15
1
2022 - 06 - 13
1
2022 - 04 - 26
1
2022 - 02 - 23
1
2022 - 02 - 04
1
2022 - 01 - 28
1
2022 - 01 - 24
1
2022 - 01 - 19
1
2022 - 01 - 14
1
2022 - 01 - 05
1
2022 - 01 - 04
1
2021 - 12 - 08
1
2021 - 12 - 02
1
2021 - 11 - 30
1
2021 - 11 - 24
1
2021 - 11 - 19
1
2021 - 11 - 17
1
2021 - 11 - 01
1
2021 - 10 - 21
1
2021 - 10 - 13
1
2021 - 10 - 08
1
2021 - 09 - 22
2
2021 - 09 - 20
1
2021 - 09 - 09
2
2021 - 09 - 07
1
Crawled Time
01:00
1
02:00
1
03:00
1
11:00
8
12:00
19
12:15
1
12:20
3
12:30
2
13:00
4
13:20
1
14:00
3
14:20
2
15:00
3
15:20
2
16:00
3
17:00
2
19:00
7
20:00
1
21:00
4
22:00
1
23:00
1
Source
www.algernonpharmaceuticals.com
3
www.biospace.com
31
www.globenewswire.com
36
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
AGNPF
save search
Algernon Pharmaceuticals CEO Christopher J. Moreau to Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar on April 16th, 2024
Published:
2024-04-11
(Crawled : 11:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
-6.08%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
ceo
pharmaceuticals
Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset
Published:
2024-04-01
(Crawled : 11:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
-18.11%
|
O:
0.37%
H:
4.5%
C:
-11.69%
drug
stroke
pharmaceuticals
research
program
Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position
Published:
2024-03-27
(Crawled : 16:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
8.31%
|
O:
25.81%
H:
0.0%
C:
0.0%
acquisition
pharmaceuticals
research
program
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD
Published:
2024-01-31
(Crawled : 12:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
12.29%
|
O:
5.02%
H:
13.06%
C:
11.46%
patent
treat
pharmaceuticals
grant
chinese
Algernon Pharmaceuticals Announces Notice of Allowance for Ifenprodil Patent in Japan for Idiopathic Pulmonary Fibrosis
Published:
2024-01-11
(Crawled : 12:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
Email alert
Add to watchlist
patent
japan
fibrosis
pharmaceuticals
Algernon Pharmaceuticals Announces Increase to Private Placement
Published:
2023-12-27
(Crawled : 12:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
34.3%
|
O:
0.0%
H:
0.0%
C:
0.0%
pharmaceuticals
Algernon Pharmaceuticals Announces Closing of Private Placement
Published:
2023-12-27
(Crawled : 21:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
34.3%
|
O:
9.2%
H:
20.51%
C:
15.38%
pharmaceuticals
Algernon Pharmaceuticals Announces Private Placement
Published:
2023-12-13
(Crawled : 01:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
17.81%
|
O:
3.68%
H:
0.0%
C:
-5.92%
pharmaceuticals
Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat NASH and NAFLD
Published:
2023-11-30
(Crawled : 17:00)
- biospace.com/
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
18.22%
|
O:
12.32%
H:
0.0%
C:
0.0%
patent
treat
pharmaceuticals
grant
chinese
nash
Algernon Pharmaceuticals Announces LOI for the Acquisition of its Chronic Cough Research Program by U.S. Based Seyltx for USD $2M and a 20% Equity Position
Published:
2023-11-22
(Crawled : 12:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
27.18%
|
O:
7.95%
H:
45.61%
C:
24.56%
acquisition
pharmaceuticals
research
program
Algernon Pharmaceuticals Receives Japanese Patent Notice of Allowance for Treatment of NASH with Repirinast
Published:
2023-11-08
(Crawled : 12:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
29.13%
|
O:
-8.27%
H:
0.0%
C:
0.0%
patent
treatment
pharmaceuticals
nash
Algernon Pharmaceuticals Announces Grant of U.S. Patent for Repirinast in NAFLD and NASH
Published:
2023-09-06
(Crawled : 11:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
-40.31%
|
O:
11.11%
H:
1.6%
C:
-4.24%
patent
pharmaceuticals
grant
nash
Algernon NeuroScience Announces 40 Patient Phase 2 Psychedelic Drug DMT Stroke Study
Published:
2023-08-08
(Crawled : 11:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
-52.31%
|
O:
-7.67%
H:
0.0%
C:
0.0%
drug
stroke
study
phase 2
Algernon Pharmaceuticals Announces Private Placement and Issuance of Shares in Connection with Financial Advisory Agreement
Published:
2023-07-14
(Crawled : 22:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
Email alert
Add to watchlist
pharmaceuticals
financial
agreement
Algernon Pharmaceuticals Engages Maxim Group to Explore Spin-Off of its Ifenprodil Phase 2 Chronic Cough Drug Development Program
Published:
2023-06-27
(Crawled : 11:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
-53.72%
|
O:
3.1%
H:
0.94%
C:
-3.21%
drug
group
pharmaceuticals
program
phase 2
Algernon Pharmaceuticals to Present Phase 2 Ifenprodil Cough Data at the 2023 American Cough Conference
Published:
2023-06-06
(Crawled : 11:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
-59.55%
|
O:
8.43%
H:
2.28%
C:
2.28%
conference
pharmaceuticals
phase 2
Algernon NeuroScience Announces Successful Completion of Highest Planned Single Dose in DMT Phase 1 Trial; Accelerates Plans for Phase 2 Stroke and TBI Studies
Published:
2023-06-05
(Crawled : 11:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
-63.7%
|
O:
0.0%
H:
1.14%
C:
-10.27%
stroke
Algernon Pharmaceuticals Receives Notice of Allowance from the Japanese Patent Office for Repirinast and the Treatment of CKD
Published:
2023-05-31
(Crawled : 11:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
-57.87%
|
O:
-4.89%
H:
0.0%
C:
0.0%
patent
treatment
pharmaceuticals
Algernon Pharmaceuticals Announces Closing of Rights Offering
Published:
2023-05-05
(Crawled : 21:00)
- globenewswire.com
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
Email alert
Add to watchlist
offering
pharmaceuticals
Algernon Pharmaceuticals Reminds Shareholders of Previously Announced Rights Offering and Approaching Cut Off Date and Time
Published:
2023-04-20
(Crawled : 12:20)
- biospace.com/
AGNPF
|
$0.0672
178.69%
100
|
Health Technology
|
-62.36%
|
O:
0.9%
H:
11.11%
C:
11.11%
offering
pharmaceuticals
← Previous
1
2
3
4
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.